Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference
Coherus BioSciences (Nasdaq: CHRS) will present at the 2024 Jefferies Global Healthcare Conference on June 6, 2024, at 8:30 a.m. EDT/5:30 a.m. PDT.
Senior management will discuss the company's latest developments and strategies.
The presentation can be accessed via a webcast on the Coherus website, and it will be available for replay until July 7, 2024.
- Coherus BioSciences is participating in a high-profile industry conference, which could enhance its visibility and investor interest.
- The availability of the webcast replay until July 7, 2024, allows a broader audience to access the presentation, potentially boosting engagement.
- The announcement does not provide specific details about the content of the presentation, leaving investors uncertain about what new information will be shared.
- There is a lack of financial or clinical data updates in the announcement, offering no immediate insight into the company's performance or progress.
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:30 a.m. Eastern Daylight Time / 5:30 a.m. Pacific Daylight Time. The presentation will be accessible via Webcast through a link on the Investor Events and Presentations section of the Coherus website: https://investors.coherus.com/events-presentations. This webcast will be available for replay until July 7, 2024.
Coherus Contact Information:
For Investors:
Jami Taylor
Head of Investor Relations
IR@coherus.com
